Health Checks After 40 and 50: What Changes and What to Screen

It usually starts with something small. You hold the menu a little farther from your face. A friend your age mentions a colonoscopy over coffee, casually, the way people once mentioned marathons. Somewhere in your early 40s, the body starts sending memos, and most of them are polite enough to ignore.

That politeness is exactly the problem. The conditions that shorten lives in midlife, high blood pressure, unhealthy cholesterol, rising blood sugar, early-stage cancers, are famously quiet. High blood pressure is called the silent killer for a reason; it produces no symptoms while it works on your arteries. A colon polyp can grow for a decade before it announces itself.

The good news is that midlife screening is not a maze. A short list of well-proven tests, done on the right schedule, covers the vast majority of what matters. Here is that list, decade by decade, with honest notes on where the evidence is strong and where it’s genuinely debated.

Why does turning 40 change the screening conversation?

Nothing dramatic happens on your 40th birthday, but the actuarial curves start bending. Arteries stiffen gradually from the 30s onward, which nudges blood pressure up. Insulin sensitivity tends to decline, especially as muscle mass slowly gives way to fat around the midsection. Cancer risk rises with accumulated cellular wear: colorectal cancer incidence climbs steeply through the 40s and 50s, and breast cancer risk roughly doubles between age 40 and age 50.

Screening exists to catch these shifts while they’re still boring: a slightly elevated reading, a small polyp, a cluster of abnormal cells on a slide. At that stage, the options are widest and the interventions gentlest. Wait for symptoms and you’ve often waited past the easy part.

There’s a second reason 40 matters: this is the decade when risk becomes personal rather than statistical. Your family history starts to rhyme with your own lab results. A parent’s heart attack at 55 or a sibling’s colon cancer at 48 changes your screening schedule in concrete, guideline-backed ways, often moving start dates up by a decade. Programs like the NHS Health Check in England formalize this logic, inviting adults 40 to 74 in for a cardiovascular risk review every five years precisely because midlife is when quiet risks compound. The American equivalent is less structured, which puts more of the scheduling burden on you. Consider this article the structure.

What should I get checked when I turn 40?

Four measurements do most of the heavy lifting at 40: blood pressure, a cholesterol panel, a blood sugar test, and body measurements such as weight and waist circumference. None requires anything more elaborate than a cuff and a blood draw, and together they estimate your cardiovascular and metabolic risk with remarkable accuracy. Layer cancer screening on top according to age and sex, and you have a complete midlife program.

Here is the core schedule for adults at average risk, drawn from MedlinePlus and major US guideline bodies:

Check	When to start	Typical frequency
Blood pressure	Already underway	At least yearly after 40
Cholesterol panel	By 40 at the latest	Every 4–6 years; more often if elevated
Blood sugar (fasting glucose or A1C)	By 35–45	Every 3 years if normal
Colorectal cancer screening	45	Stool test every 1–3 years or colonoscopy every 10
Mammogram (women, average risk)	40	Every 1–2 years
Cervical screening	Ongoing	Every 3–5 years until 65
Eye exam	Baseline at 40	Every 2–4 years, then more often after 55
Dental exam	Ongoing	Every 6–12 months

Average risk is the operative phrase. Family history of early heart disease, colorectal cancer, breast cancer, or diabetes moves start dates earlier, sometimes substantially. Bring your family’s medical story to your next appointment; it’s the cheapest diagnostic tool in medicine.

Blood pressure: the five-minute check that outworks every other test

If you do exactly one thing after reading this, make it a blood pressure reading. Nearly half of American adults have elevated blood pressure by the American Heart Association’s definitions, and a large share don’t know it, because it produces no symptoms until it has already damaged the heart, brain, kidneys, or eyes.

The numbers worth memorizing: a normal reading sits below 120/80 mm Hg. Readings of 130/80 or above cross into hypertension under current US guidelines. Between those bands lies elevated blood pressure, a genuine warning zone rather than a diagnosis, and a stage where changes to sodium intake, activity, alcohol, and sleep have their best evidence of working.

Two practical notes make this test far more useful. First, a single high reading in a clinic means little; anxiety, caffeine, a full bladder, or even a rushed walk from the parking lot can add 10 points or more. Guidelines increasingly favor confirming readings at home with a validated upper-arm cuff, taken seated, feet flat, after five quiet minutes. Second, measure both arms at least once: a consistent difference of more than 10 to 15 points between arms is worth mentioning to your clinician.

After 40, check at least yearly, and more often if readings hover near the line. It is the cheapest, fastest, most consequential number in this entire article.

How often should cholesterol be checked after 40?

Every four to six years is the standard rhythm for adults with normal results, tightening to annually or as advised once numbers drift or treatment begins. The test is a lipid panel, usually a simple blood draw, often no longer requiring fasting, that reports total cholesterol, LDL (the artery-clogging fraction), HDL (the protective fraction), and triglycerides.

What matters more than any single number is how the numbers combine with everything else about you. Clinicians now feed cholesterol results into a 10-year cardiovascular risk estimate alongside your age, blood pressure, smoking status, and diabetes history. Two people with identical LDL values can have very different risk scores, and very different recommendations. That’s a feature, not a flaw: it means decisions get made about you, not about a lab value in isolation.

The 40s are also when inherited cholesterol problems stop hiding. Familial hypercholesterolemia, markedly high LDL from birth, affects roughly 1 in 250 people and often surfaces as a heart attack in a parent or sibling before 55 (men) or 65 (women). If that describes your family, say so explicitly; it changes both the urgency and the interpretation of your panel.

One honest caveat: cholesterol is a risk factor, not a verdict. Improving your numbers shifts probability in your favor, the evidence on that is deep and consistent, but no lab result promises a particular future. The goal is stacking the odds, decade after decade.

When should blood sugar screening start, and what test is used?

US guidance now recommends screening for prediabetes and type 2 diabetes starting at age 35 for adults who are overweight, and by the mid-40s for essentially everyone. If you’ve reached 40 without a blood sugar test, you’re due.

The scale of the problem justifies the early start. The CDC estimates that roughly one in three American adults has prediabetes, blood sugar elevated above normal but below the diabetes threshold, and that more than 8 in 10 of them don’t know it. Prediabetes rarely feels like anything. It is discovered, not experienced.

Screening usually means one of three blood tests: a fasting glucose, an A1C (which reflects average blood sugar over about three months and requires no fasting), or occasionally an oral glucose tolerance test. An A1C between 5.7% and 6.4% signals prediabetes; 6.5% or above, confirmed on repeat testing, indicates diabetes. Normal results warrant a recheck every three years.

Here is why this particular screening earns its place: prediabetes is one of the most reversible findings in preventive medicine. In the landmark Diabetes Prevention Program study, structured lifestyle change, modest weight loss and about 150 minutes of weekly activity, cut progression to type 2 diabetes by 58% over three years, outperforming other approaches studied. Few screening results come with an action plan that well proven. Catch the number early, and the next move is genuinely in your hands.

Why colorectal cancer screening now starts at 45, not 50

For decades, 50 was the magic number. Then rates of colorectal cancer in adults under 50 rose steadily, people born around 1990 face roughly double the colon cancer risk of people born around 1950, and in 2021 the US Preventive Services Task Force lowered the recommended starting age to 45 for adults at average risk.

What surprises many people is the menu of options. A colonoscopy every 10 years remains the most thorough approach, because it both finds and removes precancerous polyps in a single visit. But stool-based tests done at home are legitimate, evidence-backed alternatives, not consolation prizes:

• A fecal immunochemical test (FIT), done yearly, detects hidden blood in stool.
• A stool DNA test, done every one to three years, looks for blood plus altered DNA shed by polyps and tumors.
• Flexible sigmoidoscopy every five years is another guideline-approved route.

The CDC’s position is refreshingly plain: the best test is the one you’ll actually complete. A stool test sitting finished in the mailbox beats a colonoscopy that keeps getting rescheduled. The catch is that any positive stool test must be followed by a colonoscopy: the home test is a screen, not a diagnosis.

Move the start date earlier if a first-degree relative had colorectal cancer or advanced polyps: screening typically begins at 40, or ten years before the youngest family diagnosis, whichever comes first. This is among the clearest family-history rules in all of screening.

Mammograms in your 40s: what the evidence actually says

In 2024, the US Preventive Services Task Force updated its guidance to recommend mammograms every other year for women ages 40 through 74: a notable shift from its earlier stance, which had left the 40s to individual choice. Other major organizations support annual screening as an option in the 40s. The direction of travel is clear: 40 is now the mainstream starting line for women at average risk.

The honest version of the evidence has two sides, and you deserve both. Mammography reduces breast cancer deaths: that finding is consistent across decades of trials and population studies. At the same time, screening in the 40s produces more false alarms than screening later, because younger breast tissue is denser and harder to read. Over ten years of regular screening, a substantial share of women will be called back at least once for additional imaging that turns out to be nothing. A callback is common and usually benign; it is not a diagnosis.

Density matters for another reason: it modestly raises breast cancer risk itself, and US facilities are now required to tell you your density category in your results letter. If yours reads heterogeneously dense or extremely dense, ask whether supplemental imaging makes sense for your situation.

Women with a strong family history, known genetic mutations, or prior chest radiation fall outside average-risk rules entirely and typically start earlier, sometimes with MRI added. That conversation belongs in your 30s, not your 40s.

Do I still need cervical screening in my 40s and 50s?

Yes, and this one has a genuine finish line, which makes skipping the middle years especially costly. Current US guidance for average-risk women runs to age 65: a Pap test every three years, an HPV test every five years, or the two combined every five years. Cross 65 with an adequate history of recent normal results, and screening can typically stop.

The phrase adequate history is where midlife diligence pays off. Stopping at 65 generally requires documented normal results in the preceding decade, usually two or three consecutive clean tests. Women who drift away from screening in their 50s often find they can’t retire the test at 65 after all.

Cervical cancer is one of screening’s clearest success stories. Nearly all cases are caused by persistent infection with high-risk strains of HPV, and the disease progresses slowly, typically over 10 to 20 years, through detectable precancerous stages. That long, visible runway is precisely why regular testing works so well, and why most cervical cancers today occur in women who were never screened or hadn’t been screened in many years.

Two common questions: menopause does not end the need for screening, and neither does a hysterectomy in every case: it depends on whether the cervix was removed and why the surgery was done. If you’re unsure of your own surgical history’s details, your clinician can sort it out from records. Don’t guess your way out of a test this effective.

What changes at 50?

The 50s don’t replace the 40s checklist; they add to it. Blood pressure, cholesterol, blood sugar, colorectal screening, mammograms, and cervical screening all continue on schedule. Three new conversations join the list.

First, lung cancer screening, arguably the most underused test in American preventive medicine. Adults ages 50 to 80 who have a 20 pack-year smoking history (a pack a day for 20 years, or the equivalent) and who currently smoke or quit within the past 15 years qualify for an annual low-dose CT scan. In the major US trial, this screening reduced lung cancer deaths by about 20% compared with chest X-rays. Yet uptake among eligible adults remains strikingly low, in the range of one in five or fewer. If your smoking history qualifies you, this scan deserves a place near the top of your list, delivered without judgment: eligibility is arithmetic, not a character assessment.

Second, prostate screening becomes a live question for men: a nuanced enough topic that it gets its own section below.

Third, bone health enters the frame, particularly for women, as estrogen’s protective effect on bone falls away after menopause. That, too, gets fuller treatment below.

The 50s are also when hearing changes become measurable for many adults and when a clinician may begin asking more pointedly about balance, muscle strength, and falls. None of this is fatalism. It’s the same logic as the 40s, applied one decade on: find the quiet changes while they’re still small.

Should men get a PSA test? An honest look at the debate

Prostate screening is the rare test where the official recommendation is a conversation rather than a checkbox, and that’s not bureaucratic hedging. The US Preventive Services Task Force advises that men ages 55 to 69 make an individual decision about PSA blood testing after discussing benefits and harms with a clinician, with earlier discussion (around 40 to 45) reasonable for Black men and men with a father or brother diagnosed with prostate cancer, both groups at meaningfully higher risk.

Why the ambivalence about a simple blood test? Because prostate cancer is unusual among cancers: many cases grow so slowly that they would never cause harm in a man’s lifetime. Screening finds those indolent cancers alongside the dangerous ones, and until recently, finding often meant treating, with real risks of urinary and sexual side effects for a cancer that might never have mattered. Large trials suggest PSA screening prevents some prostate cancer deaths, but at the cost of considerable overdiagnosis.

The calculus has genuinely improved. Active surveillance, closely monitoring low-risk cancers rather than treating them immediately, is now standard practice, which blunts the harm side of the ledger. MRI before biopsy has also made the diagnostic path more precise.

So the fair summary: PSA testing is neither obligatory nor dismissible. Know your risk category, have the conversation around 50 (earlier if you’re higher risk), and decide with information rather than momentum. A man who chooses either path thoughtfully has done this correctly.

Bone density: the question to ask in your 50s

Bone loss is silent right up until the fracture, which is why it belongs on a screening list at all. Women can lose up to 20% of their bone density in the five to seven years following menopause, one of the steepest physiological changes in adult life, and one that produces no sensation whatsoever.

The screening tool is a DEXA scan: a quick, painless, low-radiation X-ray of the hip and spine that takes 10 to 20 minutes and reports your density as a T-score comparing your bones with those of a healthy young adult. Standard US guidance calls for screening all women at 65, and earlier, often in the 50s, for postmenopausal women with additional risk factors: low body weight, a parent who fractured a hip, current smoking, heavy alcohol use, early menopause, certain long-term medication use, or conditions such as rheumatoid arthritis.

Men are not exempt, though their timeline runs later; bone loss accelerates for men in their 70s, and screening discussions typically begin around 70, or earlier with risk factors.

What can you do with the result? Quite a lot, which is what earns this test its place. Weight-bearing exercise and resistance training measurably slow bone loss and improve the balance and muscle strength that prevent falls in the first place. Adequate calcium and vitamin D intake supports the skeleton’s raw materials: the NIH Office of Dietary Supplements publishes intake guidance worth reading before reaching for supplements. And when density is low enough, effective medical options exist, chosen with your clinician.

Eyes, ears, and teeth: the midlife checks people quietly skip

Somewhere around 43 to 45, most people meet presbyopia: the age-related stiffening of the eye’s lens that pushes menus and phone screens to arm’s length. It’s universal and harmless. But it’s also nature’s reminder to book a comprehensive eye exam, because the 40s are when the serious, symptomless eye diseases begin their slow work.

Glaucoma is the one to respect. It damages the optic nerve gradually, starting with peripheral vision you won’t consciously miss, and vision lost to it doesn’t come back. A baseline comprehensive exam at 40, with dilation, not just a vision check for glasses, establishes your starting point; every two to four years is a typical rhythm afterward, more often after 55 or with risk factors such as family history, diabetes, or African or Hispanic ancestry, groups in which glaucoma is both more common and earlier-onset. A dilated eye exam every one to two years is standard for anyone with diabetes.

Hearing declines so gradually that families usually notice before the person does: the television creeping louder, restaurant conversation turning to guesswork. A baseline hearing test in your 50s takes under an hour, and addressing hearing loss matters beyond convenience: research increasingly links untreated hearing loss with social withdrawal and cognitive decline.

And teeth: twice-yearly dental visits continue for life. Midlife is when gum disease peaks, nearly half of adults over 30 show some periodontal disease, and when dentists often spot the first signs of diabetes, reflux, and oral cancers. The dental chair is a screening site in disguise.

The quieter screenings: mood, sleep, alcohol, and skin

Not every important check involves a needle or a scanner. US guidance recommends that all adults be screened for depression and anxiety during routine care, typically a brief written questionnaire, because midlife depression is common, treatable, and frequently mistaken for stress, hormones, or simply life. If your checkup doesn’t include those questions, raise the topic yourself. Persistent low mood, loss of interest, or hopelessness lasting more than two weeks is a medical finding, not a personality flaw.

Sleep deserves the same seriousness. Obstructive sleep apnea becomes markedly more common in midlife, and its signature triad, loud snoring, witnessed pauses in breathing, and daytime sleepiness despite a full night in bed, is worth reporting, because untreated apnea strains blood pressure and heart health. A bed partner’s observations count as clinical data here.

Alcohol screening is standard at checkups for good reason: consumption often drifts upward through the 40s and 50s, and the health math shifts with age. Answer the questions honestly; they exist to help calibrate risk, not to judge.

Skin merits an honest note. For people at average risk, the evidence for routine full-body skin exams by a clinician is genuinely uncertain: the US Preventive Services Task Force calls it insufficient to weigh benefits against harms. What is well supported: knowing your own skin, and reporting any mole that changes in size, shape, or color, any sore that won’t heal, or any new growth, especially with a history of blistering sunburns, fair skin, or family melanoma. Higher-risk individuals often warrant regular dermatology visits.

How much does a full-body health screening cost, and is it worth it?

Two very different things hide inside the phrase full-body screening, and the price gap between them is enormous.

The first is the evidence-based package described throughout this article: blood pressure, lipid panel, blood sugar, and age-appropriate cancer screening. In the US, most of these are classified as preventive services, which most insurance plans must cover without out-of-pocket cost when delivered in-network, meaning the highest-value screening program in medicine can cost you close to nothing. Paying cash, the core blood work typically runs from tens of dollars to a couple of hundred, depending on the lab and region. In England, the NHS Health Check offers a free cardiovascular risk review every five years for adults 40 to 74.

The second is the commercial executive physical or whole-body MRI/CT scan, marketed heavily to people in their 40s and 50s at prices from several hundred to several thousand dollars. Here the honest answer is uncomfortable for the marketing: no major medical body, not the FDA, not the USPSTF, not the major radiology or physician organizations, recommends whole-body imaging for people without symptoms. The predictable outcome is the incidental finding: a harmless spot on a kidney or lung that triggers months of follow-up scans, biopsies, anxiety, and expense while rarely changing health outcomes. Meanwhile, these scans can miss the very things targeted screening catches well.

Spend your attention, and your money, on the boring tests with mortality data behind them. In screening, boring is a compliment.

When to see a doctor: symptoms that shouldn't wait for a checkup

Screening is for the symptomless. The moment a symptom appears, the calendar logic changes entirely: a scheduled checkup six months away is the wrong venue for a new problem now. Contact a clinician promptly, regardless of when you were last screened, for any of the following:

• Blood where it doesn’t belong: in stool (even once), in urine, coughed up, or unexpected vaginal bleeding, including any bleeding after menopause.
• Unintentional weight loss, roughly 10 pounds or more without trying.
• A new breast lump, skin change, or nipple discharge, whatever your last mammogram showed.
• A persistent change in bowel habits lasting more than a few weeks, or ongoing difficulty swallowing.
• A cough that lingers beyond three to four weeks, or a hoarse voice that doesn’t resolve.
• A mole that changes, bleeds, or won’t heal.
• Unexplained, persistent fatigue, night sweats, or fevers.
• New or worsening headaches unlike any you’ve had before.

And treat these as emergencies, call 911 rather than booking anything: chest pain or pressure, especially spreading to the arm, jaw, or back; sudden shortness of breath; and the stroke signs summarized as FAST, face drooping, arm weakness, speech difficulty, time to call. Every minute of delayed stroke treatment costs brain tissue; heart attack outcomes hinge on the same clock.

Most symptoms on the first list will turn out to be benign. That is exactly why checking them is a rational act rather than an anxious one: the common explanations are reassuring, and the uncommon ones reward early attention more than anything else in this article.

Frequently asked questions

What should I get checked when I turn 40?

At 40, the core checks are blood pressure, a cholesterol panel, a blood sugar test, and body weight measures, plus a baseline comprehensive eye exam. Women at average risk should begin mammograms and continue cervical screening on schedule. At 45, colorectal cancer screening begins for everyone. If you have a family history of early heart disease, diabetes, or cancer, tell your clinician, several of these start dates move earlier based on that history alone.

What tests should be done after 40?

The essential blood tests after 40 are a lipid panel for cholesterol every four to six years and a fasting glucose or A1C for blood sugar every three years, alongside at least yearly blood pressure checks. Age-appropriate cancer screening layers on top: colorectal screening from 45, mammograms from 40 for many women, and cervical screening every three to five years. Kidney and liver panels or thyroid tests are added when symptoms or risk factors warrant, not routinely.

What screening should I get at 40 if I feel completely healthy?

Feeling healthy is precisely the situation screening is designed for, because high blood pressure, unhealthy cholesterol, prediabetes, and early polyps produce no symptoms. At 40, that means blood pressure, cholesterol, blood sugar, a baseline eye exam, and, for women at average risk, a first mammogram. The conditions these tests catch are far easier to address at the silent stage than after symptoms appear, which is the entire logic of preventive care.

How much does a full-body health screening cost?

Evidence-based screening often costs little or nothing out of pocket: most US insurance plans must cover recommended preventive services like blood pressure, cholesterol, diabetes, and age-appropriate cancer screening when delivered in-network. Paid privately, core blood work typically runs from tens of dollars to a few hundred. Commercial whole-body scan packages cost several hundred to several thousand dollars, but no major medical body recommends them for people without symptoms, and false alarms are their most common result.

Do I need a colonoscopy at 45 even if I have no symptoms?

You need colorectal screening at 45, but a colonoscopy is only one valid way to do it. Guideline-approved alternatives include a yearly at-home fecal immunochemical test or a stool DNA test every one to three years. The CDC’s guidance is that the best test is the one you’ll complete. Two caveats: a positive stool test must be followed by a colonoscopy, and a family history of colorectal cancer usually means starting earlier with colonoscopy directly.

How often should I have a mammogram in my 40s?

Current US Preventive Services Task Force guidance, updated in 2024, recommends a mammogram every other year for women ages 40 to 74 at average risk, while some other organizations support annual screening as an option. Expect a higher chance of callbacks in your 40s because younger breast tissue is denser and harder to read; a callback is common and usually benign. Women with strong family histories or genetic risk typically start earlier with an individualized plan.

Is a whole-body MRI scan worth it in your 40s or 50s?

Mainstream medical evidence does not support whole-body MRI or CT scans for people without symptoms, and no major guideline body recommends them. Their most common product is the incidental finding: a harmless spot that triggers follow-up scans, biopsies, and anxiety without improving health outcomes, while they can miss what targeted screening catches well. The tests with actual mortality evidence behind them, such as colorectal screening and mammography, are far cheaper and better proven.

When should men start talking about prostate screening?

Most men should discuss PSA testing with a clinician around age 50, and US guidance frames ages 55 to 69 as the window for an individualized decision. Black men and men whose father or brother had prostate cancer face higher risk and should start the conversation around 40 to 45. It’s a genuine discussion rather than an automatic test because many screen-detected prostate cancers grow slowly, and the benefits and harms of finding them are closely balanced.

What blood tests reveal heart risk after 40?

A lipid panel is the foundation: it measures LDL, HDL, total cholesterol, and triglycerides, and feeds into a 10-year cardiovascular risk estimate alongside your age, blood pressure, smoking status, and diabetes history. A blood sugar test matters too, since diabetes sharply raises heart risk. Repeat the lipid panel every four to six years when normal, more often when elevated. Blood pressure, measured by cuff rather than blood draw, completes the essential trio.

Do I need a bone density scan at 50?

Not automatically, standard US guidance screens all women at 65, but many women qualify earlier. Postmenopausal women in their 50s with risk factors such as low body weight, a parent who fractured a hip, smoking, early menopause, heavy alcohol use, or certain long-term medications should ask about a DEXA scan now. The test is quick, painless, and low-radiation, and it matters because women can lose up to 20% of bone density in the five to seven years after menopause.

References

• Health screenings for men ages 40 to 64: MedlinePlus
• Health screenings for women ages 40 to 64: MedlinePlus
• NHS Health Check: NHS
• Screening for Colorectal Cancer: CDC

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.